Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Breast Cancer
•
Radiation Oncology
•
Male Breast Cancer
Is it reasonable to use hypofractionation in early stage male breast cancer s/p lumpectomy?
What clinical and pathologic features - if any - would necessitate conventional fractionation?
Answer from: Radiation Oncologist at Community Practice
Absolutely the same as what we do for women with breast cancer.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, while we don't have an RCT for male breast...
6090
Sign in or Register to read more
12580
Related Questions
Is DCISionRT appropriate for multifocal DCIS?
Would you offer ultrahypofractionated 5-fraction whole breast only adjuvant radiation for a women with ER-/HER2+/cN+ disease with pCR in breast and nodes following Herceptin based neoadjuvant systemic therapy followed by breast conservation therapy with sentinel lymph node biopsy?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
Would you offer reirradiation for a patient who had prior MammoSite PBI?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
Do young, early-stage breast cancer patients with pCR to chemoimmunotherapy still benefit from PMRT?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
When do you consider the addition of concurrent pembrolizumab to breast irradiation?
Agreed, while we don't have an RCT for male breast...